Veracyte - 11 Year Stock Price History | VCYT
Historical daily share price chart and data for Veracyte since 2013 adjusted for splits and dividends. The latest closing stock price for Veracyte as of April 17, 2024 is 18.86.
- The all-time high Veracyte stock closing price was 81.38 on February 09, 2021.
- The Veracyte 52-week high stock price is 30.52, which is 61.8% above the current share price.
- The Veracyte 52-week low stock price is 18.73, which is 0.7% below the current share price.
- The average Veracyte stock price for the last 52 weeks is 24.53.
| Veracyte Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 23.6781 | 27.4000 | 29.1000 | 18.8600 | 18.8600 | -31.44% |
| 2023 | 24.5698 | 22.6500 | 29.9200 | 19.7200 | 27.5100 | 15.93% |
| 2022 | 23.6254 | 42.5100 | 42.5100 | 15.3100 | 23.7300 | -42.40% |
| 2021 | 46.9350 | 47.3400 | 81.3800 | 32.9400 | 41.2000 | -15.82% |
| 2020 | 32.1350 | 27.5100 | 61.8800 | 16.1300 | 48.9400 | 75.29% |
| 2019 | 24.1968 | 12.0000 | 30.9300 | 12.0000 | 27.9200 | 121.94% |
| 2018 | 9.0328 | 6.7200 | 14.8500 | 5.3900 | 12.5800 | 92.65% |
| 2017 | 7.9756 | 7.8500 | 9.4100 | 6.0500 | 6.5300 | -15.63% |
| 2016 | 6.0991 | 6.7900 | 8.1400 | 4.5100 | 7.7400 | 7.50% |
| 2015 | 8.5730 | 9.4500 | 12.3600 | 4.6900 | 7.2000 | -25.47% |
| 2014 | 12.7801 | 14.6700 | 18.4400 | 6.3300 | 9.6600 | -33.38% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.420B | $0.361B |
| Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $211.679B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $134.177B | 83.75 |
| Edwards Lifesciences (EW) | United States | $54.204B | 35.88 |
| DexCom (DXCM) | United States | $52.631B | 90.41 |
| IQVIA Holdings (IQV) | United States | $41.589B | 24.67 |
| IDEXX Laboratories (IDXX) | United States | $40.661B | 48.62 |
| Alcon (ALC) | Switzerland | $39.256B | 28.95 |
| STERIS (STE) | Ireland | $19.665B | 23.28 |
| Waters (WAT) | United States | $18.607B | 26.70 |
| Hologic (HOLX) | United States | $17.631B | 19.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.535B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.247B | 84.62 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $10.915B | 13.48 |
| Sysmex ADR (SSMXY) | Japan | $9.988B | 31.32 |
| Teleflex (TFX) | United States | $9.896B | 15.54 |
| Penumbra (PEN) | United States | $8.130B | 100.50 |
| Masimo (MASI) | United States | $7.312B | 41.00 |
| Globus Medical (GMED) | United States | $7.011B | 22.23 |
| Glaukos (GKOS) | United States | $4.796B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.997B | 25.55 |
| TransMedics (TMDX) | United States | $3.052B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.869B | 18.92 |
| Elekta AB (EKTAY) | Sweden | $2.673B | 18.34 |
| PROCEPT BioRobotics (PRCT) | United States | $2.650B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.501B | 10.27 |
| Nihon Kohden (NHNKY) | Japan | $2.368B | 20.03 |
| Inari Medical (NARI) | United States | $2.266B | 391.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.128B | 0.00 |
| RxSight (RXST) | United States | $2.009B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.820B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.862B | 15.94 |
| OPKO Health (OPK) | United States | $0.843B | 0.00 |
| Artivion (AORT) | United States | $0.837B | 96.71 |
| Paragon 28 (FNA) | United States | $0.799B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.718B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.712B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.694B | 0.00 |
| SiBone (SIBN) | United States | $0.630B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.553B | 18.77 |
| IRadimed (IRMD) | United States | $0.520B | 30.17 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.493B | 0.00 |
| Nevro (NVRO) | United States | $0.466B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.430B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.375B | 0.00 |
| NeuroPace (NPCE) | United States | $0.369B | 0.00 |
| CVRx (CVRX) | United States | $0.354B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.342B | 11.50 |
| AxoGen (AXGN) | United States | $0.306B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.271B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.261B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.259B | 0.00 |
| Accuray (ARAY) | United States | $0.221B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.193B | 0.00 |
| 908 Devices (MASS) | United States | $0.191B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.190B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.183B | 9.84 |
| Inogen (INGN) | United States | $0.162B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.151B | 0.00 |
| Neuronetics (STIM) | United States | $0.121B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.120B | 0.00 |
| Envoy Medical (COCH) | United States | $0.117B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.098B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.090B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.083B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
| Vasomedical (VASO) | United States | $0.057B | 10.32 |
| InspireMD (NSPR) | Israel | $0.053B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 106.67 |
| Autonomix Medical (AMIX) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.052B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.039B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.034B | 0.00 |
| LENSAR (LNSR) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.018B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |